Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H18N4O3 |
Molecular Weight | 278.307 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
InChI
InChIKey=BYPFEZZEUUWMEJ-UHFFFAOYSA-N
InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3
Molecular Formula | C13H18N4O3 |
Molecular Weight | 278.307 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:33:57 UTC 2023
by
admin
on
Fri Dec 15 15:33:57 UTC 2023
|
Record UNII |
SD6QCT3TSU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
369712
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
||
|
WHO-VATC |
QC04AD03
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
||
|
NDF-RT |
N0000009065
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
||
|
NCI_THESAURUS |
C744
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
||
|
NCI_THESAURUS |
C1327
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
||
|
NCI_THESAURUS |
C221
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
||
|
LIVERTOX |
NBK548672
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
||
|
NDF-RT |
N0000175895
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
||
|
WHO-ATC |
C04AD03
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
637086
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY | |||
|
3309
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
Pentoxifylline
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
SD6QCT3TSU
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
SD6QCT3TSU
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
1508901
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY | |||
|
m8519
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY | Merck Index | ||
|
758481
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY | |||
|
D010431
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY | |||
|
6493-05-6
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
SUB09705MIG
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
4740
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY | |||
|
8013
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY | RxNorm | ||
|
2099
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
DB00806
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
7095
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
CHEMBL628
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
DTXSID7023437
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
C733
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY | |||
|
PENTOXIFYLLINE
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY | |||
|
229-374-5
Created by
admin on Fri Dec 15 15:33:57 UTC 2023 , Edited by admin on Fri Dec 15 15:33:57 UTC 2023
|
PRIMARY | |||
|
100000091628
Created by
admin on Fri Dec 15 15:33:58 UTC 2023 , Edited by admin on Fri Dec 15 15:33:58 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
URINE
|
||
|
DEGRADENT -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
MINOR
|
||
|
PARENT -> METABOLITE ACTIVE |
|
||
|
METABOLITE ACTIVE -> PARENT |
OCCURS DURING FIRST PASS METABOLISM. CONCENTRATION MAY 10x HIGHER THAN PENTOXIFYLLINE
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE INACTIVE -> PARENT |
APPEARS TO OCCUR PREDOMINANTLY IN RED BLOOD CELLS THROUGH NADPH REDUCTASE ENZYMES
MAJOR
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||